Through metabolomics, the metabolic underpinnings of cellular changes can be rapidly pinpointed, directing process development scientists to key areas for cell culture optimization.
BioPharm International-06-02-2009
By considering stability as part of the cell line selection and cell banking paradigm, we can ensure that instability problems are not observed during clinical or commercial manufacturing.
Microbial systems such as E. Coli and yeasts are most effective for producing antibody fragments.
Advertisement
Advertisement
Trending on BioPharm International
1
RNAnalytics CPHI Interview, Part Two: Nanoparticle Case Studies and Response to US mRNA Pullback
2
How Is AI Transforming Biomanufacturing and Biopharma Workforce Training?
3
How Enzymatic Platforms May Change the Therapeutic RNA Supply Chain
4
Achieving Real Impact Navigating the Data and Regulatory Barriers to AI Adoption in Bio/pharma
5
